A STUDY OF HEPATIC FIBROSIS IN CHRONIC LIVER DISEASE PATIENTS USING NON-INVASIVE METHODS OF APRI SCORE AND TRANSIENT ELASTOGRAPHY
Abstract
Background: APRI and Transient elastography is recommended as the preferred non-invasive test to assess for the presence of cirrhosis (APRI score >2 in adults) in resource-limited settings. The present study was planned with an objective to study hepatic fibrosis in chronic liver disease patients using non-invasive methods of APRI score and transient elastography.
Methodology: The present study was a Cross-sectional Study conducted on cases with Chronic liver disease. The demographic details like age, gender, aetiology and duration of disease were recorded. Patients were assessed using APRI score and Transient Elastography. Stiffness is measured in terms of ‘liver fibrosis index, and ‘strain ratio’.
Results: It was seen that there was a positive correlation between APRI and LF index with correlation coefficient(r) of 0.30033 (p<0.05) and APRI and Strain index with correlation coefficient(r) of 0.2924 (p<0.05). While studying the diagnostic importance of APRI index, it was observed that it has a sensitivity of 87.50% while specificity of 35.29%.
Conclusion: Transient elastography and APRI score are promising non-invasive methods, complementary to each other and can be used to detect the presence and extent of fibrosis in chronic liver disease. APRI score is a sensitive but not a specific test to detect fibrosis in patients of chronic liver disease.
Keywords
Full Text:
PDFReferences
Maurizio Soresi, Lydia Giannitrapani, Melchiorre Cervello, Anna Licata, and Giuseppe Montalto. Non invasive tools for the diagnosis of liver cirrhosis. World J Gastroenterol. 2014 Dec 28; 20(48): 18131–18150.
Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. Geneva: World Health Organization; 2015 Mar. 4, Recommendations: Non-invasive assessment of liver disease stage at baseline and during follow up. Available from: https://www.ncbi.nlm.nih.gov/books/NBK305554/ assessed on 10/02/2018.
Yoav Lurie, Muriel Webb, Ruth Cytter-Kuint, Shimon Shteingart, and Gerardo Z Lederkremer. Non-invasive diagnosis of liver fibrosis and cirrhosis. World J Gastroenterol. 2015 Nov 7; 21(41): 11567–11583.
Julius Wilder, Keyur Patel. The clinical utility of FibroScan as a noninvasive diagnostic test for liver disease. Med Devices (Auckl). 2014; 7: 107–114.
Sajja K C, Mohan D P, andRockey D C : Age and Ethnicity in Cirrhosis. J Investig Med. 2014 October ; 62(7): 920–926.
Xing Wang, Shang-Xiong Lin, Jin Tao et al. Study of liver cirrhosis over ten consecutive years in Southern China. World J Gastroenterol2014 October 7; 20(37): 13546-13555.
Romanas Zykus1, 3,Laimas Jonaitis1,Vitalija Petrenkienė et al. Combination of transient elastography with serum-based non-invasive tests improves prediction of liver fibrosis in patients with chronic hepatitis C: a prospective cohort study. ACTA MEDICA LITUANICA. 2015. Vol. 22. No. 2. P. 77–84.
Wai, C. T., Greenson, J. K., Fontana, R. J., Kalbfleisch, J. D., Marrero, J. A., Conjeeevaram, H.S., Lok, AS-F.: A simple non-invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitisC. Hepatology, 2003, 38, 518–526.
Gabriella Pár, ÁronVincze, TimeaBerki et al. Serum Fibrosis Markers (Procollagen-III-Peptide, Hyaluronic Acid, Transforming Growth Factor -1), Aspartate-Aminotransferase to Platelet Ratio Index (APRI), and Transient Elastography (FibroScan) in Patients with Chronic HCV Infection. CEMED.2005. vol 11. 101-118.
Mendes L.C, P.A. Ferreira P. A., Miotto N. et al : Transient elastography and APRI score:looking at false positives and false negatives.Diagnostic performance and association to fibrosisstaging in chronic hepatitis C. Brazilian Journal of Medical and Biological Research 2016. 49(9).
Refbacks
- There are currently no refbacks.